Evgenia Gatov1, Laura Rosella1, Maria Chiu1, Paul A Kurdyak2. 1. Institute for Clinical Evaluative Sciences (Gatov, Rosella, Chiu, Kurdyak); Dalla Lana School of Public Health (Rosella, Chiu), University of Toronto; Institute for Mental Health Policy Research (Kurdyak), Centre for Addiction and Mental Health, Toronto, Ont. 2. Institute for Clinical Evaluative Sciences (Gatov, Rosella, Chiu, Kurdyak); Dalla Lana School of Public Health (Rosella, Chiu), University of Toronto; Institute for Mental Health Policy Research (Kurdyak), Centre for Addiction and Mental Health, Toronto, Ont. Paul.Kurdyak@camh.ca.
Abstract
BACKGROUND: We examined mortality time trends and premature mortality among individuals with and without schizophrenia over a 20-year period. METHODS: In this population-based, repeated cross-sectional study, we identified all individual deaths that occurred in Ontario between 1993 and 2012 in persons aged 15 and over. We plotted overall and cause-specific age- and sex-standardized mortality rates (ASMRs), stratified all-cause ASMR trends by sociodemographic characteristics, and analyzed premature mortality using years of potential life lost. Additionally, we calculated mortality rate ratios (MRRs) using negative binomial regression with adjustment for age, sex, income, rurality and year of death. RESULTS: We identified 31 349 deaths among persons with schizophrenia, and 1 589 902 deaths among those without schizophrenia. Mortality rates among people with schizophrenia were 3 times higher than among those without schizophrenia (adjusted MRR 3.12, 95% confidence interval 3.06-3.17). All-cause ASMRs in both groups declined in parallel over the study period, by about 35%, and were higher for men, for those with low income and for rural dwellers. The absolute ASMR difference also declined throughout the study period (from 16.15 to 10.49 deaths per 1000 persons). Cause-specific ASMRs were greater among those with schizophrenia, with circulatory conditions accounting for most deaths between 1993 and 2012, whereas neoplasms became the leading cause of death for those without schizophrenia after 2005. Individuals with schizophrenia also died, on average, 8 years younger than those without schizophrenia, losing more potential years of life. INTERPRETATION: Although mortality rates among people with schizophrenia have declined over the past 2 decades, specialized approaches may be required to close the persistent 3-fold relative mortality gap with the general population.
BACKGROUND: We examined mortality time trends and premature mortality among individuals with and without schizophrenia over a 20-year period. METHODS: In this population-based, repeated cross-sectional study, we identified all individual deaths that occurred in Ontario between 1993 and 2012 in persons aged 15 and over. We plotted overall and cause-specific age- and sex-standardized mortality rates (ASMRs), stratified all-cause ASMR trends by sociodemographic characteristics, and analyzed premature mortality using years of potential life lost. Additionally, we calculated mortality rate ratios (MRRs) using negative binomial regression with adjustment for age, sex, income, rurality and year of death. RESULTS: We identified 31 349 deaths among persons with schizophrenia, and 1 589 902 deaths among those without schizophrenia. Mortality rates among people with schizophrenia were 3 times higher than among those without schizophrenia (adjusted MRR 3.12, 95% confidence interval 3.06-3.17). All-cause ASMRs in both groups declined in parallel over the study period, by about 35%, and were higher for men, for those with low income and for rural dwellers. The absolute ASMR difference also declined throughout the study period (from 16.15 to 10.49 deaths per 1000 persons). Cause-specific ASMRs were greater among those with schizophrenia, with circulatory conditions accounting for most deaths between 1993 and 2012, whereas neoplasms became the leading cause of death for those without schizophrenia after 2005. Individuals with schizophrenia also died, on average, 8 years younger than those without schizophrenia, losing more potential years of life. INTERPRETATION: Although mortality rates among people with schizophrenia have declined over the past 2 decades, specialized approaches may be required to close the persistent 3-fold relative mortality gap with the general population.
Authors: Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht Journal: World Psychiatry Date: 2011-02 Impact factor: 49.548
Authors: Robin M Murray; Pak Sham; Jim Van Os; Jolanta Zanelli; Mary Cannon; Colm McDonald Journal: Schizophr Res Date: 2004-12-01 Impact factor: 4.939
Authors: Mika Gissler; Thomas Munk Laursen; Urban Ösby; Merete Nordentoft; Kristian Wahlbeck Journal: BMC Public Health Date: 2013-09-11 Impact factor: 3.295
Authors: Nicholas Chak Lam Yung; Corine Sau Man Wong; Joe Kwun Nam Chan; Eric Yu Hai Chen; Wing Chung Chang Journal: Schizophr Bull Date: 2021-03-16 Impact factor: 9.306
Authors: Paul Kurdyak; Emilie Mallia; Claire de Oliveira; Andre F Carvalho; Nicole Kozloff; Juveria Zaheer; Wanda M Tempelaar; Kelly K Anderson; Christoph U Correll; Aristotle N Voineskos Journal: Schizophr Bull Date: 2021-04-29 Impact factor: 9.306
Authors: Nicole Kozloff; George Foussias; Janet Durbin; Sanjeev Sockalingam; Jean Addington; Donald Addington; Augustina Ampofo; Kelly K Anderson; Melanie Barwick; Sarah Bromley; Jasmyn E A Cunningham; Simone Dahrouge; Lillian Duda; Catherine Ford; Sheila Gallagher; John D Haltigan; Joanna Henderson; Alexia Jaouich; Dielle Miranda; Patrick Mitchell; Josette Morin; Claire de Oliveira; Valerie Primeau; Eva Serhal; Sophie Soklaridis; Diana Urajnik; Krista Whittard; Juveria Zaheer; Paul Kurdyak; Aristotle N Voineskos Journal: BMJ Open Date: 2020-06-03 Impact factor: 2.692